Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.44M$3.44Mderived+117.7% vs Q4 2017 Net Income-$7.74M-$7.74MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,722,945+210.8% Operating Incomederived-$4,926,434N/M Operating Cash Flowderived-$1,367,757N/M Free Cash Flowderived-$3,032,655N/M Margins · derivedGross margin79.2%+23.7 pt vs Q4 2017
Operating margin-143.2%−80.6 pt vs Q4 2017
Net margin-225.1%−141.9 pt vs Q4 2017
ended Dec 31, 2018 · filed Apr 16, 2019 · 106 d after period end